Vice President of Clinical Development
Dr. Paul Kosnik is responsible for business development and managing interactions with the clinical trial sites and medical experts. He also serves as the Tissue Genesis Principal Investigator for the Critical Limb Ischemia trial funded by the federal government.
Previously, Dr. Kosnik served as the Vice President of Engineering at Tissue Genesis and is intimately familiar with the technologies used to isolate cells from adipose (fat) tissue.
Dr. Kosnik is a member of the International Tissue Engineering Society, the International Federation for Adipose Therapeutics and Science, and the International Society for Cellular Therapy. He has received numerous patents in the fields of regenerative medicine, cell therapy, and tissue engineering, and has published on regenerative medicine. He was an Adjunct Professor at Brown University, a visiting scientist in the Harvard-MIT Division of Human Sciences and Technology, and a member of the External Advisory Board for the University of North Carolina at Chapel Hill. He has a B.S., Masters Degree, and Ph.D. from the University of Michigan in Biomedical Engineering.